Document is current
Any future updates will be listed below
-
Authors
Bazzi, Angela R.
Valasek, Chad J.
Stamos-Buesig, Tara
Eger, William H.
Harvey-Vera, Alicia
Vera, Carlos F.
Syvertsen, Jennifer L.
Storholm, Erik D.
Bartholomew, Tyler S.
Tookes, Hansel E.
Strathdee, Steffanie A.
Pines, Heather A.
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (P30AI036214)
National Institute of Allergy and Infectious Diseases (P30AI036214)
National Institute of Allergy and Infectious Diseases (P30AI036214)
National Institute of Allergy and Infectious Diseases (P30AI036214)
National Institute on Drug Abuse (R34DA058389)
National Institute on Drug Abuse (T32DA023356)
National Institute on Drug Abuse (T32DA023356)
National Institute on Drug Abuse (R01DA049644)
National Institute on Drug Abuse (R01DA049644)
National Institute on Drug Abuse (R34DA058389)
National Institute on Drug Abuse (R34DA058389)
National Institute on Drug Abuse (DP2DA053720)
National Institute on Drug Abuse (DP2DA053720)
National Institute on Drug Abuse (R01DA049644)
National Institute on Drug Abuse (R34DA058389)
- License Information
-
More Information
Article History
Received: 10 October 2023
Accepted: 26 January 2024
First Online: 4 February 2024
Declarations
:
: Participants provided verbal informed consent to participate in this study. The institutional review board of the University of California, San Diego reviewed and approved all study procedures and granted a waiver of documentation of consent.
: Participants provided consent to have de-identified information about themselves published.
: Drs. Tookes and Bartholomew report receiving research funding from Gilead Sciences and Viiv Healthcare. All other authors report no conflicts of interest to declare.
